Skip to main content

Table 3 Incremental costs of various HPV vaccines at the national level (US$)

From: Human papillomavirus vaccination at the national and provincial levels in China: a cost-effectiveness analysis using the PRIME model

Vaccines

Incremental cost per

Cervical cancer prevented

Life saved

Life year saved

DALY prevented

Domestic bivalent vaccine

58,779

144,329

7879

7213

Imported bivalent vaccine

106,546

261,618

14,282

13,074

Imported quadrivalent vaccine

148,034

363,490

19,843

18,165

Imported 9-valent vaccine

146,554

359,905

18,112

16,939